Tongkat Ali vs Fadogia Agrestis

Fadogia agrestis has NO published human randomised controlled trials. None. Its entire testosterone reputation is built on animal work — principally Yakubu 2005, a 5-day study in male albino rats. There is no human efficacy trial to point to, at any dose, for any endpoint. Everything else is anecdote and podcast discussion.

Fadogia's famous testosterone effect is a rat finding. Yakubu 2005 reported a dose-dependent rise in serum testosterone in male albino rats given the aqueous stem extract at 18-100 mg/kg for 5 days. Impressive in rodents — but it has never been reproduced, or even measured, in humans. For a human buying decision, the proven-in-humans effect size is effectively unknown.

This is fadogia's biggest problem. The same research group that reported the testosterone effect also found the extract altered testicular function indices in rats (Yakubu 2008) and caused liver and kidney cellular toxicity (Yakubu 2009) — a dose-dependent, organ-level toxicity signal. Crucially, NO human safety study exists to show whether these effects appear in people. Unknown safety plus a documented animal toxicity flag is the worst possible combination.

Fadogia is unstandardised. There is no eurycomanone-equivalent marker, no accepted assay, and huge variability between products — you genuinely cannot know how much active compound you're taking. Its mechanism (a proposed androgen-like / luteinising action) is a hypothesis from rat work, never confirmed in humans. You can't reliably dose it, and you can't fully explain how it works.

Fadogia's popularity is a case study in how anecdote outruns evidence. It got hot because it was discussed on influential podcasts, not because trials validated it. Anecdote can't separate a real effect from placebo or regression to the mean, and it can't catch a slow toxicity problem. For a careful person, 'people online say it works' is not a reason to accept an unquantified organ-toxicity risk.